Skip to main content
TipRanks
Go Ultimate75% OFF

Starling Oncology Institute (STLN) Q3 2022 Earnings Report

213 Followers

STLN Q3 2022 EPS Results

Actual EPS
-$0.17
Consensus EPS
-$0.18
Beat/Miss
Beat by +$0.01
One Year Ago EPS
-$0.02

STLN Q3 2022 Revenue Results

Actual Revenue
$64.98M
Expected Revenue
$68.95M
Beat/Miss
Missed by -$3.97M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2022
Date
11/09/2022
Time
After Close
Conference Call
Wednesday, November 9, 2022
STLN Upcoming Earnings

Starling Oncology Institute's next earnings date is estimated for March 11, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

STLN Q3 2022 Earnings Call
0:00 / 0:00

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

STLN Earnings History

STLN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 11, 20272026 (Q4)-0.04--0.06――
Nov 05, 20262026 (Q3)-0.05-0.13-0.147.14% (+0.01)
Aug 06, 20262026 (Q2)-0.06-0.08-0.1546.67% (+0.07)
May 07, 20262026 (Q1)-0.09-0.02-0.2190.48% (+0.19)
Mar 12, 20262025 (Q4)-0.09-0.06-0.1457.14% (+0.08)
Nov 13, 20252025 (Q3)-0.11-0.14-0.1822.22% (+0.04)
Aug 13, 20252025 (Q2)-0.12-0.15-0.1711.76% (+0.02)
May 14, 20252025 (Q1)―-0.21-0.224.55% (+0.01)
Mar 24, 20252024 (Q4)―-0.14-0.2133.33% (+0.07)
Nov 13, 20242024 (Q3)―-0.18-0.195.26% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed